Suppr超能文献

帕金森病与癌症之间的关联:情况愈发复杂。

The associations between Parkinson's disease and cancer: the plot thickens.

作者信息

Feng Danielle D, Cai Waijiao, Chen Xiqun

机构信息

MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA.

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA USA.

出版信息

Transl Neurodegener. 2015 Oct 26;4:20. doi: 10.1186/s40035-015-0043-z. eCollection 2015.

Abstract

Epidemiological studies support a general inverse association between the risk of cancer development and Parkinson's disease (PD). In recent years however, increasing amount of eclectic evidence points to a positive association between PD and cancers through different temporal analyses and ethnic groups. This positive association has been supported by several common genetic mutations in SNCA, PARK2, PARK8, ATM, p53, PTEN, and MC1R resulting in cellular changes such as mitochondrial dysfunction, aberrant protein aggregation, and cell cycle dysregulation. Here, we review the epidemiological and biological advances of the past decade in the association between PD and cancers to offer insight on the recent and sometimes contradictory findings.

摘要

流行病学研究支持癌症发生风险与帕金森病(PD)之间存在普遍的负相关关系。然而近年来,越来越多的综合性证据通过不同的时间分析和种族群体表明,PD与癌症之间存在正相关关系。这种正相关关系得到了一些常见基因突变的支持,如SNCA、PARK2、PARK8、ATM、p53、PTEN和MC1R,这些基因突变会导致细胞变化,如线粒体功能障碍、异常蛋白质聚集和细胞周期失调。在此,我们回顾过去十年中PD与癌症关联方面的流行病学和生物学进展,以深入了解近期一些有时相互矛盾的研究结果。

相似文献

1
The associations between Parkinson's disease and cancer: the plot thickens.
Transl Neurodegener. 2015 Oct 26;4:20. doi: 10.1186/s40035-015-0043-z. eCollection 2015.
2
Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions.
Neurol Res. 2017 Nov;39(11):965-972. doi: 10.1080/01616412.2017.1368141. Epub 2017 Aug 22.
5
Genetic and environmental findings in early-onset Parkinson's disease Brazilian patients.
Mov Disord. 2008 Jul 15;23(9):1228-33. doi: 10.1002/mds.22032.
6
Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
Neurobiol Aging. 2013 Nov;34(11):2695.e1-7. doi: 10.1016/j.neurobiolaging.2013.05.022. Epub 2013 Jun 29.
7
Parkinson's disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus.
Parkinsonism Relat Disord. 2016 Dec;33:115-121. doi: 10.1016/j.parkreldis.2016.09.028. Epub 2016 Sep 28.
8
Cancer and Parkinson's disease: the odd couple.
Drugs Today (Barc). 2011 Mar;47(3):215-22. doi: 10.1358/dot.2011.47.3.1519657.
10
Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
Parkinsonism Relat Disord. 2016 Mar;24:89-94. doi: 10.1016/j.parkreldis.2015.12.018. Epub 2015 Dec 30.

引用本文的文献

3
Evolving Landscape of Parkinson's Disease Research: Challenges and Perspectives.
ACS Omega. 2025 Jan 8;10(2):1864-1892. doi: 10.1021/acsomega.4c09114. eCollection 2025 Jan 21.
4
Causal association between Parkinson's disease and cancer: a bidirectional Mendelian randomization study.
Front Aging Neurosci. 2024 Nov 5;16:1432373. doi: 10.3389/fnagi.2024.1432373. eCollection 2024.
5
Head and Neck Cancer: A Potential Risk Factor for Parkinson's Disease?
Cancers (Basel). 2024 Jul 8;16(13):2486. doi: 10.3390/cancers16132486.
6
Association between Parkinson's Disease and Cancer: New Findings and Possible Mediators.
Int J Mol Sci. 2024 Mar 31;25(7):3899. doi: 10.3390/ijms25073899.
7
Suppression of Glioblastoma Stem Cell Potency and Tumor Growth via LRRK2 Inhibition.
Int J Stem Cells. 2024 Aug 30;17(3):319-329. doi: 10.15283/ijsc24032. Epub 2024 Apr 8.
8
Comprehensive Analysis and Experimental Validation of the Parkinson's Disease Lysosomal Gene ACP2 and Pan-cancer.
Biochem Genet. 2024 Dec;62(6):4408-4431. doi: 10.1007/s10528-023-10652-x. Epub 2024 Feb 3.
9
Glutamate Receptors and C-ABL Inhibitors: A New Therapeutic Approach for Parkinson's Disease.
Cent Nerv Syst Agents Med Chem. 2024;24(1):22-44. doi: 10.2174/0118715249268627231206115942.
10
Longitudinal study of the inverse relationship between Parkinson's disease and cancer in Korea.
NPJ Parkinsons Dis. 2023 Jul 22;9(1):116. doi: 10.1038/s41531-023-00562-5.

本文引用的文献

1
Association Between Parkinson Disease and Risk of Cancer in Taiwan.
JAMA Oncol. 2015 Aug;1(5):633-40. doi: 10.1001/jamaoncol.2015.1752.
2
Mutations in LRRK2 potentiate age-related impairment of autophagic flux.
Mol Neurodegener. 2015 Jul 11;10:26. doi: 10.1186/s13024-015-0022-y.
3
α-Synuclein interactions with phospholipid model membranes: Key roles for electrostatic interactions and lipid-bilayer structure.
Biochim Biophys Acta. 2015 Oct;1848(10 Pt A):2002-12. doi: 10.1016/j.bbamem.2015.06.021. Epub 2015 Jun 26.
5
Inhibition of amyloid-β plaque formation by α-synuclein.
Nat Med. 2015 Jul;21(7):802-7. doi: 10.1038/nm.3885. Epub 2015 Jun 22.
6
PARK2 gene and familial lung cancer: what is the link?
Future Oncol. 2015;11(12):1707-10. doi: 10.2217/fon.15.79.
7
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
Nature. 2015 Jun 18;522(7556):340-4. doi: 10.1038/nature14547. Epub 2015 Jun 10.
8
LRRK2 Promotes Tau Accumulation, Aggregation and Release.
Mol Neurobiol. 2016 Jul;53(5):3124-3135. doi: 10.1007/s12035-015-9209-z. Epub 2015 May 27.
9
LRRK2 Pathways Leading to Neurodegeneration.
Curr Neurol Neurosci Rep. 2015 Jul;15(7):42. doi: 10.1007/s11910-015-0564-y.
10
The Role of α-Synuclein and LRRK2 in Tau Phosphorylation.
Parkinsons Dis. 2015;2015:734746. doi: 10.1155/2015/734746. Epub 2015 Apr 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验